Nuvalent Statistics
Total Valuation
Nuvalent has a market cap or net worth of $7.88 billion. The enterprise value is $6.51 billion.
Important Dates
The last earnings date was Thursday, February 26, 2026, before market open.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Nuvalent has 78.62 million shares outstanding. The number of shares has increased by 9.45% in one year.
| Current Share Class | 73.18M |
| Shares Outstanding | 78.62M |
| Shares Change (YoY) | +9.45% |
| Shares Change (QoQ) | +4.13% |
| Owned by Insiders (%) | 2.46% |
| Owned by Institutions (%) | 73.69% |
| Float | 48.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.28 |
| P/TBV Ratio | 6.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.27
| Current Ratio | 15.27 |
| Quick Ratio | 15.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.70% and return on invested capital (ROIC) is -22.34%.
| Return on Equity (ROE) | -36.70% |
| Return on Assets (ROA) | -20.27% |
| Return on Invested Capital (ROIC) | -22.34% |
| Return on Capital Employed (ROCE) | -31.35% |
| Weighted Average Cost of Capital (WACC) | 11.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.87M |
| Employee Count | 228 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Nuvalent has paid $585,000 in taxes.
| Income Tax | 585,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.66% in the last 52 weeks. The beta is 1.32, so Nuvalent's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | +33.66% |
| 50-Day Moving Average | 103.40 |
| 200-Day Moving Average | 89.83 |
| Relative Strength Index (RSI) | 43.85 |
| Average Volume (20 Days) | 495,730 |
Short Selling Information
The latest short interest is 5.68 million, so 7.22% of the outstanding shares have been sold short.
| Short Interest | 5.68M |
| Short Previous Month | 5.81M |
| Short % of Shares Out | 7.22% |
| Short % of Float | 11.65% |
| Short Ratio (days to cover) | 11.34 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -414.31M |
| Pretax Income | -424.79M |
| Net Income | -425.38M |
| EBITDA | n/a |
| EBIT | -414.31M |
| Earnings Per Share (EPS) | -$5.85 |
Full Income Statement Balance Sheet
The company has $1.37 billion in cash and n/a in debt, with a net cash position of $1.37 billion or $17.45 per share.
| Cash & Cash Equivalents | 1.37B |
| Total Debt | n/a |
| Net Cash | 1.37B |
| Net Cash Per Share | $17.45 |
| Equity (Book Value) | 1.25B |
| Book Value Per Share | 15.96 |
| Working Capital | 1.30B |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -275.21M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Nuvalent does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.45% |
| Shareholder Yield | -9.45% |
| Earnings Yield | -5.40% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for Nuvalent is $135.33, which is 35.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $135.33 |
| Price Target Difference | 35.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |